Kaleido Biosciences Inc. (KLDO) at a glance

Kaleido Biosciences Inc. (KLDO) is a micro-cap Healthcare company. It trades at $0, with a 0% profit margin and revenue growth of 102.5%. It does not pay a dividend. Vestovix scores it 47/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Safety (1/100). It carries above-market volatility, so expect larger swings.

Price
$0.00
Market cap
$4,262
P/E ratio
n/a
Dividend yield
None
Beta
35.72
52-week range
$0.00 to $0.01
Vestovix Score47/ 100How this works
Value
58
Growth
94
Income
40
Safety
1
Momentum
12